These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1340 related articles for article (PubMed ID: 24627125)
1. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway. Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125 [TBL] [Abstract][Full Text] [Related]
2. β-elemene reverses the drug resistance of A549/DDP lung cancer cells by activating intracellular redox system, decreasing mitochondrial membrane potential and P-glycoprotein expression, and inducing apoptosis. Yao C; Jiang J; Tu Y; Ye S; Du H; Zhang Y Thorac Cancer; 2014 Jul; 5(4):304-12. PubMed ID: 26767017 [TBL] [Abstract][Full Text] [Related]
3. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin. Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235 [TBL] [Abstract][Full Text] [Related]
4. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells. Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854 [TBL] [Abstract][Full Text] [Related]
5. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin. Gong X; Liu J; Zhang D; Yang D; Min Z; Wen X; Wang G; Li H; Song Y; Bai C; Li J; Zhou J PLoS One; 2017; 12(8):e0182410. PubMed ID: 28771580 [TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potential. Chiu TL; Su CC Int J Mol Med; 2010 Feb; 25(2):231-6. PubMed ID: 20043132 [TBL] [Abstract][Full Text] [Related]
7. Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms. Ye MX; Zhao YL; Li Y; Miao Q; Li ZK; Ren XL; Song LQ; Yin H; Zhang J Phytomedicine; 2012 Jun; 19(8-9):779-87. PubMed ID: 22483553 [TBL] [Abstract][Full Text] [Related]
8. Apatinib resensitizes cisplatin-resistant non-small cell lung carcinoma A549 cell through reversing multidrug resistance and suppressing ERK signaling pathway. Liu ZL; Jin BJ; Cheng CG; Zhang FX; Wang SW; Wang Y; Wu B Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5370-5377. PubMed ID: 29243778 [TBL] [Abstract][Full Text] [Related]
9. Preliminary evaluation of the potential role of β-elemene in reversing erlotinib-resistant human NSCLC A549/ER cells. Lin L; Li L; Chen X; Zeng B; Lin T Oncol Lett; 2018 Sep; 16(3):3380-3388. PubMed ID: 30127938 [TBL] [Abstract][Full Text] [Related]
10. Investigation of the mechanism and apoptotic pathway induced by 4β cinnamido linked podophyllotoxins against human lung cancer cells A549. Kamal A; Nayak VL; Bagul C; Vishnuvardhan MV; Mallareddy A Apoptosis; 2015 Nov; 20(11):1518-29. PubMed ID: 26386574 [TBL] [Abstract][Full Text] [Related]
11. [The roles of holothurian glycosaminoglycan combined with cisplatin on proliferation and chemotherapeutic response in A549 human lung adenocarcinoma cell]. Jin Q; Zhu XH; Lin CZ; Zhang H; Cao YW; Ding XQ; Lyu ZH Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):252-257. PubMed ID: 29730910 [No Abstract] [Full Text] [Related]
12. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells. Hu Z; Zeng Q; Zhang B; Liu H; Wang W Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870 [TBL] [Abstract][Full Text] [Related]
13. C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells. Xie C; Pan Y; Hao F; Gao Y; Liu Z; Zhang X; Xie L; Jiang G; Li Q; Wang E APMIS; 2014 Dec; 122(12):1251-8. PubMed ID: 25131138 [TBL] [Abstract][Full Text] [Related]
14. A flavonoid isolated from Streptomyces sp. (ERINLG-4) induces apoptosis in human lung cancer A549 cells through p53 and cytochrome c release caspase dependant pathway. Balachandran C; Sangeetha B; Duraipandiyan V; Raj MK; Ignacimuthu S; Al-Dhabi NA; Balakrishna K; Parthasarathy K; Arulmozhi NM; Arasu MV Chem Biol Interact; 2014 Dec; 224():24-35. PubMed ID: 25289772 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells. Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211 [TBL] [Abstract][Full Text] [Related]
16. Denbinobin induces apoptosis in human lung adenocarcinoma cells via Akt inactivation, Bad activation, and mitochondrial dysfunction. Kuo CT; Hsu MJ; Chen BC; Chen CC; Teng CM; Pan SL; Lin CH Toxicol Lett; 2008 Feb; 177(1):48-58. PubMed ID: 18262737 [TBL] [Abstract][Full Text] [Related]
17. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway. Wang R; Ma L; Weng D; Yao J; Liu X; Jin F Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028 [TBL] [Abstract][Full Text] [Related]
18. Role of intracellular glutathione in cell sensitivity to the apoptosis induced by tumor necrosis factor {alpha}-related apoptosis-inducing ligand/anticancer drug combinations. Meurette O; Lefeuvre-Orfila L; Rebillard A; Lagadic-Gossmann D; Dimanche-Boitrel MT Clin Cancer Res; 2005 Apr; 11(8):3075-83. PubMed ID: 15837763 [TBL] [Abstract][Full Text] [Related]
19. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression. Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490 [TBL] [Abstract][Full Text] [Related]
20. [Research on the mechanism of ginsenoside Rh2 reversing the resistance of lung adenocarcinoma cells to cisplatin]. Hu S; Yu JY; Xiong LJ; Hu CP; Zhang YX Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(4):264-8. PubMed ID: 20356543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]